Table 4 Cases of Stenotrophomonas maltophilia-related peritonitis in PD patients in the literature
No. | Author | Age/sex | Dialysis duration (months) | Primary KD | Diabetes mellitus | No. of previous peritonitis episodes | Antibiotic therapy | Outcome |
|---|---|---|---|---|---|---|---|---|
1 | Szeto et al. [7] | NA | NA | NA | NA | 0 | VCM + IPM → CAZ + GM → CPFX | Catheter removal |
2 | Szeto et al. [7] | NA | NA | NA | NA | 1 | VCM + IPM → CAZ → CPFX → TMP–SMX | Catheter removal |
3 | Szeto et al. [7] | NA | NA | NA | NA | 3 | VCM + IPM → CAZ | Catheter removal |
4 | Szeto et al. [7] | NA | NA | NA | NA | 1 | VCM + IPM → CAZ → CPFX | Catheter removal |
5 | Szeto et al. [7] | NA | NA | NA | NA | 2 | VCM + IPM → CAZ + NTL | Catheter removal |
6 | Szeto et al. [7] | NA | NA | NA | NA | 0 | VCM + IPM → CAZ → ABPC | Catheter removal |
7 | Taylor et al. [3] | 61/M | 60 | NA | NA | 1.6 | NA | Continued PD |
8 | Taylor et al. [3] | 64/M | 9 | NA | NA | 1.3 | NA | Continued PD |
9 | Taylor et al. [3] | 52/F | 26 | NA | NA | 0.0 | NA | Catheter removal |
10 | Taylor et al. [3] | 19/F | 68 | NA | NA | 0.9 | NA | Catheter removal |
11 | Taylor et al. [3] | 16/F | 6 | NA | NA | 2.0 | NA | Catheter removal |
12 | Taylor et al. [3] | 43/F | 99 | NA | NA | 0.7 | NA | Continued PD |
13 | Taylor et al. [3] | 16/M | 1 | NA | NA | 0.0 | NA | Catheter removal |
14 | N. AI-Hilali et al. [8] | 63/M | 43 | DN | ( +) | 4 | VCM + GM CAZ + CPFX | Catheter removal |
15 | N. AI-Hilali et al. [8] | 65/F | 19 | DN | ( +) | 2 | VCM + GM CAZ + CPFX | Catheter removal |
16 | Cheng et al. [9] | 47/M | NA | NA | NA | NA | NA | Catheter removal |
17 | Baek et al. [4] | 61/F | 32 | DN | ( +) | 3 | CEZ + TOB → CAZ + AMK → CAZ + AMK + PIPC | Continued PD |
18 | Baek et al. [4] | 34/F | 24 | DN | ( +) | 1 | CEZ + TOB | Continued PD |
19 | Baek et al. [4] | 48/F | 15 | DN | ( +) | 2 | VCM + CAZ + CPFX → CAZ → TMP–SMX + CTRX + CPFX → AMPH-B | Catheter removal |
20 | Tzanetou K et al. [10] | 60/M | 96 | Nephrolithiasis | NA | Repeatedly | CAZ + TMP–SMX | Continued PD |
21 | Tzanetou K et al. [10] | 64/F | 120 | PKD | NA | 2 | CAZ + AMK → TMP–SMX | Continued PD |
22 | Tzanetou K et al. [10] | 64/F | 96 | CGN | NA | 0 | VCM + CAZ → AMK + CPFX + TMP–SMX | Continued PD |
23 | Tzanetou K et al. [10] | 64/F | 96 | CGN | NA | 1 | TMP–SMX | Continued PD |
24 | Tzanetou K et al. [10] | 40/M | 96 | Nephrolithiasis | NA | 0 | TMP–SMX + TIPC/CVA | Catheter removal |
25 | Machuca E et al. [11] | 54/F | 23 | Alport disease | NA | 0 | VCM + CAZ → TMP–SMX + AMK | Continued PD |
26 | Lee et al. [12] | NA | NA | NA | NA | NA | NA | Continued PD |
27 | Azak A et al. [13] | 57/F | 36 | DN | ( +) | 0 | VCM + CAZ → CAZ + LVFX | Continued PD |
28 | Beatriz Millan- Diaz et al. [14] | 54/M | NA | Calcineurin toxicity | NA | 3 | VCM + CAZ + FLCZ → TMP–SMX | Catheter removal |
29 | Our study | 63/M | 12 | DN | ( +) | 0 | CEZ + ISP → VCM + MEPM → CAZ + PZFX → MINO + LVFX + TMP–SMX | Continued PD |
30 | Our study | 64/M | 13 | DN | ( +) | 1 | MINO + PZFX + TMP–SMX → PZFX + TMP–SMX + FLCZ | Catheter removal |
31 | Our study | 53/M | 15 | DN | ( +) | 0 | CEZ + ISP → VCM + MEPM → VCM + PZFX | Catheter removal |
32 | Our study | 71/M | 10 | DN | ( +) | 0 | CEZ + ISP → VCM + MEPM → PZFX + RFP → CAZ + RFP | Catheter removal |
33 | Our study | 79/F | 5 | Unknown | ( −) | 1 | CEZ + ISP → PZFX | Catheter removal |